SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0001193125-22-192989
Filing Date
2022-07-13
Accepted
2022-07-13 17:10:33
Documents
3

Document Format Files

Seq Description Document Type Size
1 SC 13D d343001dsc13d.htm SC 13D 55338
2 EX-99.1 d343001dex991.htm EX-99.1 565781
3 EX-99.2 d343001dex992.htm EX-99.2 48279
  Complete submission text file 0001193125-22-192989.txt   671120
Mailing Address 1 PLUCKEMIN WAY - SUITE 103 BEDMINSTER NJ 07921
Business Address 1 PLUCKEMIN WAY - SUITE 103 BEDMINSTER NJ 07921 212-461-2315
TYME TECHNOLOGIES, INC. (Subject) CIK: 0001537917 (see all company filings)

IRS No.: 453864597 | State of Incorp.: DE | Fiscal Year End: 0331
Type: SC 13D | Act: 34 | File No.: 005-90053 | Film No.: 221081599
SIC: 2834 Pharmaceutical Preparations

Mailing Address 35 CAMBRIDGE PARK DRIVE CAMBRIDGE MA 02140
Business Address 35 CAMBRIDGE PARK DRIVE CAMBRIDGE MA 02140 617-744-1340
Syros Pharmaceuticals, Inc. (Filed by) CIK: 0001556263 (see all company filings)

IRS No.: 453772460 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D
SIC: 2834 Pharmaceutical Preparations